NYSE$CRL

Charles River Laboratories International Inc · Q1 2023 earnings

Q1 2023 earnings · · Investor relations

Briefing

Charles River Labs reported a strong start to the year, driven by healthy demand and pricing in the DSA segment.

Charles River Laboratories announced first-quarter 2023 results with revenue of $1.03 billion, a 12.6% increase from Q1 2022. GAAP EPS was $2.01 and Non-GAAP EPS was $2.78. The company updated its 2023 guidance to reflect the strong first-quarter performance.

  • First-quarter revenue reached $1.03 billion, up 12.6% year-over-year.
  • GAAP earnings per share were $2.01, an 11.0% increase from Q1 2022.
  • Non-GAAP earnings per share were $2.78, a 1.1% increase from Q1 2022.
  • Organic revenue growth was 15.4%, driven by DSA and RMS segments.

Headline financials

Total Revenue

$1.03B

Previous: $914M+12.6%
EPS (adj)

$2.78

Previous: $2.75+1.1%
Free Cash Flow

$103M

Previous: $93M+10.9%
Net Income

$103M

Previous: $93M+10.9%
Operating Income

$168M

Previous: $149M+12.8%
Gross Profit

$24.1M

Previous: $7.9M+204.9%
Cash & Equivalents

$202M

Previous: $242M-16.7%
Total Assets

$7.7B

Previous: $7.08B+8.8%
Stock-Based Comp

$13.5M

Previous: $14.6M-7.9%

Revenue & EPS history

Charles River Labs · Revenue · Quarterly

$1.03B

Q1 2023+12.6%vs Q1 2022
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Revenue by segment

Charles River Labs · $1.03B total across 3 segments · Q1 2023

  • Discovery & Safety Assessment
    $662M+21.7%
  • Research Models & Services
    $200M+13.2%
  • Manufacturing Solutions
    $167M-13.4%

Forward guidance

The Company is narrowing its revenue growth and earnings per share outlooks to reflect the strong first-quarter financial performance and expectations for the remainder of the year that are largely consistent with its initial outlook.

Tailwinds

  • Revenue growth, reported 2.0% – 4.5%
  • Impact of divestitures/(acquisitions), net ~1.5%
  • Impact of 53rd week in 2022 ~1.5%
  • Unfavorable/(favorable) impact of foreign exchange 0.0% - (0.5)%
  • Revenue growth, organic 5.0% – 7.5%

Headwinds

  • Cambodian NHP supply constraints
  • Acquisition-related amortization ~$2.00
  • Acquisition and integration-related adjustments ~$0.10
  • Venture capital and other strategic investment losses/(gains), net $0.03
  • Other items $0.30 – $0.35

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2023

Historical avgQ1 2023

+0.1%

Avg return

Earnings day

+0.5%

Avg return

5 days after

+0.7%

Avg return

30 days after

47%

32 / 68 earnings

Positive

+18.4%

Q1 2025

Best reaction

-13.3%

Q3 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+1.8%-9.0%-0.1%
Q4 2025-1.8%+3.1%-3.1%
Q3 2025-5.5%-5.0%+3.6%
Q1 2025+18.4%+24.0%+25.4%
Q4 2024+6.9%+10.4%+8.3%
Q3 2024+11.5%+17.0%+1.7%
Q2 2024-11.7%-15.1%-17.8%
Q1 2024-3.0%-1.0%-8.7%
Q4 2023+11.4%+11.2%+17.6%
Q3 2023-7.3%-7.0%+11.8%
Q2 2023+5.5%+5.2%-3.2%
Q1 2023+2.7%+1.0%+6.1%
Q4 2022-6.7%-9.0%-20.4%
Q3 2022+4.8%+9.0%+7.4%
Q2 2022-6.6%-9.4%-17.8%
Q1 2022-1.2%-8.9%-3.3%
Q4 2021-6.7%-6.1%-8.3%
Q3 2021-12.2%-13.4%-17.3%
Q2 2021-0.3%-0.4%+9.3%
Q1 2021+4.0%+3.2%-0.1%
Q4 2020+2.0%-1.1%-0.0%
Q3 2020+2.6%+7.0%+3.7%
Q2 2020+6.8%+7.3%+0.4%
Q1 2020+11.1%+12.0%+24.2%
Q4 2019+8.6%+11.9%-21.3%
Q3 2019-2.5%+1.1%+12.0%
Q2 2019-5.1%-10.3%-7.0%
Q1 2019-4.2%-4.1%-10.4%
Q4 2018+8.1%+9.0%+11.1%
Q3 2018+8.8%+6.8%+3.0%
Q2 2018-5.2%-6.6%-1.6%
Q1 2018+0.3%-1.0%+8.5%
Q4 2017+8.2%+6.0%+9.9%
Q3 2017-13.3%-14.3%-11.9%
Q2 2017-1.7%-0.2%+10.0%
Q1 2017-3.8%-2.3%+2.8%
Q4 2016+7.6%+7.3%+8.4%
Q3 2016-9.0%-5.1%-3.0%
Q2 2016-0.0%-3.1%-3.0%
Q1 2016+2.5%
Q4 2015+3.9%
Q3 2015+5.7%
Q2 2015+1.4%
Q1 2015-8.8%
Q4 2014+6.3%
Q3 2014-1.9%
Q2 2014+6.0%
Q1 2014-6.6%
Q4 2013-1.6%
Q3 2013-1.2%
Q2 2013+3.4%
Q1 2013-3.9%
Q4 2012+0.9%
Q3 2012-5.3%
Q2 2012+2.3%
Q1 2012+1.8%
Q4 2010-1.3%
Q4 2011-1.3%
Q3 2011-5.0%
Q2 2011-9.4%
Q1 2010-2.4%
Q1 2011-0.1%
Q4 2008-0.9%
Q3 2010-4.4%
Q3 2009-4.4%
Q2 2010+3.6%
Q4 2009+3.6%
Q2 2009+3.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro